Safety and Efficacy of Expanded Allogeneic AD-MSCs in Patients With Moderate to Severe Psoriasis

NCT03265613 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

7

Enrollment

OTHER

Sponsor class

Conditions

Mesenchymal Stromal Cells
Psoriasis
Drug Toxicity
Drug Effect

Interventions

BIOLOGICAL: adipose-derived multipotent mesenchymal stem cells

Sponsor

Guangdong Provincial Hospital of Traditional Chinese Medicine